Free Trial

Abbott Laboratories (ABT) Competitors

Abbott Laboratories logo
$123.81 +3.30 (+2.74%)
Closing price 03:59 PM Eastern
Extended Trading
$123.80 -0.01 (-0.01%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ABT vs. DXCM, ISRG, TSLA, ABBV, BSX, ELV, ITGR, JNJ, MDT, and TMO

Should you be buying Abbott Laboratories stock or one of its competitors? The main competitors of Abbott Laboratories include DexCom (DXCM), Intuitive Surgical (ISRG), Tesla (TSLA), AbbVie (ABBV), Boston Scientific (BSX), Elevance Health (ELV), Integer (ITGR), Johnson & Johnson (JNJ), Medtronic (MDT), and Thermo Fisher Scientific (TMO).

Abbott Laboratories vs. Its Competitors

Abbott Laboratories (NYSE:ABT) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

In the previous week, Abbott Laboratories had 96 more articles in the media than DexCom. MarketBeat recorded 113 mentions for Abbott Laboratories and 17 mentions for DexCom. DexCom's average media sentiment score of 1.36 beat Abbott Laboratories' score of 0.73 indicating that DexCom is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Abbott Laboratories
52 Very Positive mention(s)
13 Positive mention(s)
23 Neutral mention(s)
12 Negative mention(s)
3 Very Negative mention(s)
Positive
DexCom
12 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Abbott Laboratories presently has a consensus target price of $144.47, suggesting a potential upside of 16.69%. DexCom has a consensus target price of $99.60, suggesting a potential upside of 18.73%. Given DexCom's stronger consensus rating and higher probable upside, analysts clearly believe DexCom is more favorable than Abbott Laboratories.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Abbott Laboratories
0 Sell rating(s)
5 Hold rating(s)
16 Buy rating(s)
1 Strong Buy rating(s)
2.82
DexCom
0 Sell rating(s)
4 Hold rating(s)
16 Buy rating(s)
2 Strong Buy rating(s)
2.91

Abbott Laboratories has a net margin of 32.43% compared to DexCom's net margin of 12.90%. DexCom's return on equity of 30.05% beat Abbott Laboratories' return on equity.

Company Net Margins Return on Equity Return on Assets
Abbott Laboratories32.43% 18.83% 10.88%
DexCom 12.90%30.05%10.00%

Abbott Laboratories has a beta of 0.73, suggesting that its share price is 27% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.44, suggesting that its share price is 44% more volatile than the S&P 500.

75.2% of Abbott Laboratories shares are held by institutional investors. Comparatively, 97.8% of DexCom shares are held by institutional investors. 0.5% of Abbott Laboratories shares are held by company insiders. Comparatively, 0.3% of DexCom shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Abbott Laboratories has higher revenue and earnings than DexCom. Abbott Laboratories is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Abbott Laboratories$41.95B5.13$13.40B$7.7116.06
DexCom$4.03B8.16$576.20M$1.3462.60

Summary

DexCom beats Abbott Laboratories on 9 of the 16 factors compared between the two stocks.

Get Abbott Laboratories News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABT and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ABT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ABT vs. The Competition

MetricAbbott LaboratoriesMED PRODUCTS IndustryMedical SectorNYSE Exchange
Market Cap$209.67B$10.12B$5.52B$20.73B
Dividend Yield1.96%2.05%3.80%3.69%
P/E Ratio15.5216.5928.0427.57
Price / Sales5.1329.60429.5359.01
Price / Cash18.3122.2635.8422.13
Price / Book4.483.578.124.66
Net Income$13.40B$235.43M$3.25B$994.58M
7 Day Performance-6.17%-1.67%0.97%-0.29%
1 Month Performance-6.45%2.91%7.36%4.91%
1 Year Performance23.70%-16.44%31.31%10.53%

Abbott Laboratories Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ABT
Abbott Laboratories
4.988 of 5 stars
$123.81
+2.7%
$144.47
+16.7%
+15.3%$209.67B$41.95B15.52114,000Trending News
Earnings Report
Ex-Dividend
Analyst Forecast
High Trading Volume
DXCM
DexCom
4.7868 of 5 stars
$85.21
+2.2%
$98.50
+15.6%
-26.6%$33.35B$4.15B63.4810,300Positive News
Analyst Forecast
ISRG
Intuitive Surgical
4.7015 of 5 stars
$518.99
+1.4%
$592.86
+14.2%
+21.1%$185.95B$8.35B76.0715,638Positive News
Upcoming Earnings
Analyst Revision
TSLA
Tesla
4.6873 of 5 stars
$316.02
+0.8%
$300.19
-5.0%
+28.5%$1.02T$97.69B173.42125,665Trending News
Upcoming Earnings
ABBV
AbbVie
4.7844 of 5 stars
$191.06
-0.7%
$211.29
+10.6%
+9.1%$337.24B$56.33B81.2455,000Trending News
Ex-Dividend
Analyst Revision
BSX
Boston Scientific
4.6219 of 5 stars
$104.48
+1.2%
$116.09
+11.1%
+35.1%$154.46B$16.75B76.2153,000Trending News
Upcoming Earnings
ELV
Elevance Health
4.9753 of 5 stars
$339.25
-0.4%
$491.07
+44.7%
-42.1%$76.71B$177.01B13.25104,200Trending News
Earnings Report
Dividend Announcement
Analyst Forecast
Insider Trade
Gap Down
ITGR
Integer
3.8897 of 5 stars
$119.01
-0.8%
$145.00
+21.8%
-7.7%$4.15B$1.72B56.3811,000News Coverage
Positive News
Upcoming Earnings
JNJ
Johnson & Johnson
4.7823 of 5 stars
$156.56
-0.2%
$171.00
+9.2%
+4.1%$376.50B$89.33B17.41138,100Trending News
Earnings Report
Dividend Announcement
Analyst Forecast
Options Volume
Analyst Revision
MDT
Medtronic
4.6379 of 5 stars
$89.56
-0.4%
$97.47
+8.8%
+10.2%$114.88B$33.54B24.7495,000Positive News
Analyst Forecast
Analyst Revision
TMO
Thermo Fisher Scientific
4.9933 of 5 stars
$427.00
-1.8%
$600.30
+40.6%
-23.4%$161.19B$42.90B25.04125,000Trending News
Upcoming Earnings
Analyst Forecast
Analyst Revision

Related Companies and Tools


This page (NYSE:ABT) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners